Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the gut to treat multiple sclerosis
Laura Ghezzi, Claudia Cantoni, Gabriela Veronica Pinget, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The gut microbiota in multiple sclerosis varies with disease activity
Florence Thirion, Finn Sellebjerg, Yong Fan, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 60
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Félipe Esparza Salazar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1184-1184
Open Access | Times Cited: 61
A Brief Overview on BDNF-Trk Pathway in the Nervous System: A Potential Biomarker or Possible Target in Treatment of Multiple Sclerosis?
Giuseppe Schirò, Salvatore Iacono, Paolo Ragonese, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 42
Epsilon toxin–producing Clostridium perfringens colonize the multiple sclerosis gut microbiome overcoming CNS immune privilege
Yinghua Ma, David R. Sannino, Jennifer R. Linden, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 9
Open Access | Times Cited: 32
Mechanisms of inflammation after ischemic stroke in brain-peripheral crosstalk
Ling Xie, Ming He, Caidi Ying, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 10
The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review
Xiaoxiao Lin, Shuai Wang, Yue Gao
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 9
Probiotics as modulators of gut-brain axis for cognitive development
Akash Kumar, Bhagavathi Sundaram Sivamaruthi, Swarnima Dey, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 9
Gut–Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond
Julia Zißler, Veit Rothhammer, Mathias Linnerbauer
Cells (2024) Vol. 13, Iss. 6, pp. 497-497
Open Access | Times Cited: 8
The microbiota-gut-brain-immune interface in the pathogenesis of neuroinflammatory diseases: a narrative review of the emerging literature
Alison Warren, Yvonne Nyavor, Nikkia Zarabian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review
Bruno Bonnechère, Najaf Amin, Cornelia M. van Duijn
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13665-13665
Open Access | Times Cited: 37
Fatty acids role in multiple sclerosis as “metabokines”
Haojun Yu, Shuwei Bai, Yong Hao, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 31
Impact of Microbiome–Brain Communication on Neuroinflammation and Neurodegeneration
Iris Stolzer, E Scherer, Patrick Süß, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14925-14925
Open Access | Times Cited: 18
Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders
Małgorzata Anna Marć, Rafał Jastrząb, Jennifer Mytych
Nutrients (2022) Vol. 14, Iss. 19, pp. 3967-3967
Open Access | Times Cited: 23
A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1052-1052
Open Access | Times Cited: 22
NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota
Julia Niño-Narvión, Marina Idalia Rojo-López, Patricia Martinez-Santos, et al.
Nutrients (2023) Vol. 15, Iss. 13, pp. 2992-2992
Open Access | Times Cited: 15
Harnessing and delivering microbial metabolites as therapeutics via advanced pharmaceutical approaches
Lindsey Williams, Shijie Cao
Pharmacology & Therapeutics (2024) Vol. 256, pp. 108605-108605
Closed Access | Times Cited: 5
Probiotics alleviate painful diabetic neuropathy by modulating the microbiota–gut–nerve axis in rats
Ye Jiang, Jing Yang, Min Wei, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Multi-omics Mendelian Randomization Reveals Immunometabolic Signatures of the Gut Microbiota in Optic Neuritis and the Potential Therapeutic Role of Vitamin B6
Jingzhi Wang, Xuehao Cui
Molecular Neurobiology (2025)
Open Access
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
Dorota Kujawa, Łukasz Łaczmański, Sławomir Budrewićz, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 11
The role of the “gut microbiota-mitochondria” crosstalk in the pathogenesis of multiple sclerosis
Huan Tian, Dunbing Huang, Jiaqi Wang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
The Role of Gut-derived Short-Chain Fatty Acids in Multiple Sclerosis
Mohamed J. Saadh, Hani Moslem Ahmed, Zaid Khalid Alani, et al.
NeuroMolecular Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3
Gut microbiome-modulated dietary strategies in EAE and multiple sclerosis
Kristina Hoffman, William J. Doyle, Sean M. Schumacher, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 8
(R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice
Xingming Wang, Lijia Chang, Yunfei Tan, et al.
Brain Research Bulletin (2021) Vol. 177, pp. 316-323
Open Access | Times Cited: 18
Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health
Jessica Maiuolo, Vincenzo Musolino, Micaela Gliozzi, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2711-2711
Open Access | Times Cited: 13
Multiple sclerosis: a narrative overview of current pharmacotherapies and emerging treatment prospects
Piotr Olejnik, Zuzanna Roszkowska, Sylwia Adamus, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 926-943
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top